|
|
|
Agenda: Day 2
Thursday, February 26, 2004
Held at Hyatt Regency on Capitol Hill
|
8:00 a.m. |
Welcome and Introduction
Nancy-Ann DeParle
Senior Advisor, JPMorgan Partners
Former Administrator, Health Care Financing Administration
Washington, DC
(Co chair)
|
8:15 a.m. |
The Role of CMS in Implementing the New Medicare Prescription Drug Legislation
Leslie V. Norwalk
Acting Deputy Director
Centers for Medicare & Medicaid Services
Department of Health and Human Services
Baltimore, MD
|
9:00 a.m. |
The Democratic Perspective
Congressman Fortney Pete Stark (D - CA)
Ranking Democrat, Health Subcommittee
Ways and Means Committee
United States House of Representatives
Washington, DC
|
9:30 a.m. |
The Role of FDA in Implementing the New Medicare Prescription Drug Legislation
Mark B. McClellan, MD, Ph.D.
Commissioner of Food and Drugs
Food and Drug Administration
Rockville, MD
|
10:15 p.m. |
The Republican Perspective
Congresswoman Nancy L. Johnson (R - CT)
Chairwoman, Health Subcommittee
Ways and Means Committee
United States House of Representatives
Washington, DC
|
10:45 a.m. |
Break
|
11:15 a.m. |
The Perspective of Pharmaceutical Manufacturers
Fred Hassan, MBA
Chairman and Chief Executive Officer
Schering-Plough Corporation
Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA)
Kenilworth, NJ
Presentation Material (Acrobat)
Presentation Material (Microsoft Word)
|
11:45 a.m. |
The Perspective of PBMs
Barrett Toan
President and Chief Executive Officer, Express Scripts, Inc.
Chair, Pharmaceutical Care Management Association
Maryland Heights, MO
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
12:15 p.m. |
Networking Luncheon
|
1:15 p.m. |
Introduction to Afternoon Plenary Session
David Chin, MD, MBA
Partner, Healthcare Consulting Practice
PricewaterhouseCoopers LLP
Former President and Medical Director
Health Centers Division, Harvard Community Health Plan
Boston, MA
(Co-chair)
|
1:30 p.m. |
The Perspective of Health Plans
Leonard D. Schaeffer
Chairman and Chief Executive Officer
WellPoint Health Networks
Thousand Oaks, CA
|
2:00 p.m. |
The Provider Perspective
Charles N. Kahn, III (Chip)
President, Federation of American Hospitals
Former President, Health Insurance Association of America
Washington, DC
|
2:30 p.m. |
The Purchaser Perspective
Robert S. Galvin, MD, MBA
Director, Global Healthcare
General Electric Company
Founding Member, The Leap Frog Group
Vice Chair, Washington Business Group on Health
Fairfield, CT
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
3:00 p.m. |
The Perspective of Pharmacies and Pharmacists
John M. Coster, Ph.D., R.Ph.
Vice President, Policy and Programs
National Association of Chain Drug Stores
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Susan C. Winckler, R.Ph., JD
Vice President, Policy & Communications and Staff Counsel
American Pharmacists Association
Washington, DC
|
3:45 p.m. |
Break
|
4:15 p.m. |
Understanding the New Medicare Legislation: Medicare's History and Contemporary Politics
Theodore R. Marmor, Ph.D.
Professor of Public Policy & Management
Yale University School of Management
New Haven, CT
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
4:45 p.m. |
Long Term Health Policy Implications
Drew E. Altman, Ph.D.
President and Chief Executive Officer
Henry J. Kaiser Family Foundation
Former Commissioner, New Jersey Department of Human Services
Washington, DC
|
5:15 p.m. |
A Roundtable on Prescription Drug Coverage Policy and Politics
Robert E. Moffit, Ph.D.
Director, Center for Health Policy Studies
The Heritage Foundation
Washington, DC
Ronald F. Pollack
Executive Director, Families USA
Washington, DC
John Rother, Esq.
Director of Policy and Strategy, AARP
Former Staff Director and Chief Counsel
Special Committee on Aging
United States Senate
Washington, DC
John K. Iglehart
Founding Editor, Health Affairs
Washington, DC
(Moderator)
|
6:30 p.m. |
Adjournment and Networking Reception
|
|
